论文部分内容阅读
目的:评价多种药物联用治疗小肠恶性淋巴瘤患者的临床疗效。方法:选取2008年1月—2009年12月间收治的行小肠恶性淋巴瘤患者50例为研究对象,均采用手术治疗和抗癌药物治疗,并评价其临床疗效。结果:治疗后患者临床疗效与存活率,术后生存小于2年者为26例,3~5年者为18例,5年以上者为6例。结论:小肠恶性淋巴瘤要早发现早治疗,这对于患者的存活率和生命质量具有重要意义。
Objective: To evaluate the clinical efficacy of multiple drugs in the treatment of patients with small intestinal malignant lymphoma. Methods: Fifty patients with malignant lymphoma of small intestine who were admitted from January 2008 to December 2009 were selected as the research object. All the patients were treated with surgery and anticancer drugs, and the clinical efficacy was evaluated. Results: After treatment, the clinical efficacy and survival rate of patients after operation were 26 cases less than 2 years, 18 cases 3 to 5 years and 6 cases more than 5 years. Conclusion: Early treatment of malignant lymphoma of the small intestine should be detected early, which is of great significance for the survival rate and quality of life of patients.